Our Recommendations
- Beschluss der STIKO zur 19. Aktualisierung der COVID-19-Impfempfehlung und die dazugehörige wissenschaftliche Begründung (2022)
- Recommandations provisoires concernant l’utilisation du vaccin ChAdOx1-S [recombinant] contre la COVID-19 (vaccin anti-COVID-19 AZD1222 Vaxzevria™ d’AstraZeneca, COVISHIELD™ de SII) (2021)
- Statement on the Efficacy of the AstraZeneca COVID-19 Vaccine (ChAdOx1 nCoV-19) against the SARS-CoV-2 Variants (2021)
- Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™) (2022)
- Déclaration sur l’efficacité du vaccin COVID-19 d’AstraZeneca (ChAdOx1 nCoV-19) contre les variants du SARS-CoV-2 (2021)
New Publications
- AZD1222 vaccine against COVID-19 developed by Oxford University and Astra Zeneca: Background paper (2021)
- Statement on the Efficacy of the AstraZeneca COVID-19 Vaccine (ChAdOx1 nCoV-19) against the SARS-CoV-2 Variants (2021)
- Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca (2021)
- Oxford–AstraZeneca COVID-19 vaccine efficacy (2021)
- Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™) (2022)
Filter
26
Featured
Recommendations
6
New Publications
12
Language
Document type
Fact sheets
14
Guidelines
6
Studies & Reports
4
Manuals
1
Situation Updates
1
Countries / Regions
West and Central Africa
3
East and Southern Africa
3
India
3
Germany
2
Brazil
2
South Sudan
2
Western and Central Europe
1
South Korea
1
Authors & Publishers
Publication Years
Category
COVID-19
12
Guidelines
2
Policies
1
Toolboxes
Vaxzevria (Astra Zeneca)
26
Country specific documents
2
SARS-CoV-2 Variants
2
Pediatrics
1
For Parents & Children
1
Immunization Guidelines
1
Moderna
1
Biontech/Pfizer Comirnaty
1
Johnson & Johnson
1
Covaxin
1
Booster Doses
1
Este documento de referência foi preparado pelo Grupo de Trabalho sobre Vacinas contra COVID-19 do Grupo Consultivo Estratégico de Especialistas em Imunização (SAGE) para orientar as discussões do SAGE em sua reunião extraordinária de 8 de fevereiro de 2021, que resultou na publicação do do...
orientations provisoires, première publication: 10 février 2021, mise à jour : 21 avril 2021, dernière mise à jour : 30 juillet 2021
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021
